New Once-Daily pill could simplify tough bone infection treatment
NCT ID NCT05753215
First seen Jan 24, 2026 · Last updated Apr 30, 2026 · Updated 9 times
Summary
This study compares a new antibiotic, omadacycline, taken once daily, to standard oral antibiotics for bone and joint infections. About 180 adults who need 4 to 12 weeks of treatment will be randomly assigned to either the new drug or standard care. The goal is to see if omadacycline works just as well and is easier for patients to stick with.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Lundquist Institute For Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California, 90502, United States
Conditions
Explore the condition pages connected to this study.